In this episode, we explore why the traditional 'clinical-first, value-later' model is becoming a strategic liability and why integrating HEOR into CRO operations is the new industry standard. Join us as Aaron Berger and Dr. Mir Sohail Fazeli break down how to eliminate vendor silos to build a seamless, lifecycle-wide evidence narrative that ensures regulatory success.
To learn more about this, check out the deep-dive blog here:
Podden och tillhörande omslagsbild på den här sidan tillhör
HealthEconomics.com. Innehållet i podden är skapat av HealthEconomics.com och inte av,
eller tillsammans med, Poddtoppen.